Abstract:Background: The optimal management of ischemic mitral regurgitation (IMR) is controversial. The aim of this study was to examine our eight years' experience of surgical treatment in patients with IMR, and to compare outcomes of mitral valve repair versus replacement with concomitant coronary artery bypass grafting (CABG). Methods: A retrospective, observational, cohort study was undertaken to collect data on consecutive patients with IMR and coronary artery disease who received CABG and mitral valve surgery in our hospital between January 2008 and December 2015. Basic patient characteristics, operative data, and postoperative clinical outcomes were examined. Results: The series included 22 consecutive patients (21 male; 1 female). The mean age was 62.1±11.4 years old. The mean preoperative left ventricular ejection fraction (LVEF) was 33.4%±15.4%. The mean cardiopulmonary bypass (CPB) time was 165.4±38.4 minutes, and the mean aortic cross clamp time was 113.8±33.6 minutes. Eighteen patients underwent CABG plus mitral valve repair, and four patients underwent CABG plus mitral valve replacement (MVR). There were three early in-hospital mortalities: two in the mitral valve repair group, and one in the replacement group. The follow-up was complete in all patients, with a mean follow-up duration of 3.1±2.3 years. The mean last LVEF was 35.3%±17.7%. There were 2 late mortalities. Both were from the repair group. The overall late survival rate was 81.6%, with 83.0% in the repair group and 75.0% in the replacement group. In patients with echocardiography follow-up of more than or equal to 1 year duration, the residual or recurrent mitral regurgitation rates were 0.0% in the replacement group and 57.1% in the repair group. One patient in the repair group later underwent MVR due to severe regurgitation postoperatively. Conclusions: Our preliminary findings showed that the surgical outcome of mitral valve repair might be comparable to that of MVR in terms of early mortality and long-term survival. However, mitral valve repair was associated with a higher residual or recurrent mitral regurgitation rate. According to the latest literature, the role of MVR can justifiably be indicated for severe IMR. As for moderate IMR, CABG alone without mitral valve intervention may provide similar clinical outcomes.

Surgical repair and replacement for native mitral valve infective endocarditis

The Role of Microbes in Surgical Decision Making for Infective Endocarditis: Mitral Valve Repair or Replacement?

Mitral Valve Repair and Mitral Valve Replacement in the Treatment of Infective Endocarditis Mitral Valve Regurgitation in the Long-Term Curative Effect Comparison

To repair or to replace in mitral valve infective endocarditis? an updated meta-analysis

Mitral valve repair and replacement in infectious endocarditis: a systematic review and meta-analysis of clinical outcome

Outcome of patient undergoing redo mitral valve surgery with incidence rate of mitral valve infective endocarditis

Chronic infection and severe mitral regurgitation: first of all, do not harm

Outcomes of Emergency or Urgent Mitral Valve Repair in Patients with Papillary Muscle Rupture and Active Infective Endocarditis.

Similar survival after mitral valve replacement or repair for ischemic mitral regurgitation: a meta-analysis

Patient and Surgeon Predictors of Mitral and Tricuspid Valve Repair for Infective Endocarditis

Mitral valve repair versus replacement in patients with ischemic mitral regurgitation

[Clinical outcome and factors affecting surgical decision for repair versus replacement in patients with mitral regurgitation]

Contemporary Outcomes of Degenerative Mitral Valve Surgery in a Regional Tertiary Care Center

Outcome of mitral valve repair or replacement for non-ischemic mitral regurgitation: a systematic review and meta-analysis

Mitral Valve Repair with a Semi-Rigid C-Band Annuloplasty Ring in Ischemic Mitral Regurgitation: Still a Viable Surgical Option?

Mitral Valve Repair vs. Replacement by Different Etiologies ― A Nationwide Population-Based Cohort Study ―

When Should the Mitral Valve Be Repaired or Replaced in Patients With Ischemic Mitral Regurgitation?

Early and late Results after Surgical Mitral Valve Repair: A High-Volume Center Experience

Mitral Valve Repair or Replacement? Our "Road Map" for the Appropriate Strategy

Tricuspid valve repair for infective endocarditis

Mid-term results of mitral valve replacement and repair: current clinical experience, technical aspects, and risk factor analysis